key: cord-0715118-9iyys0w1
authors: Zhao, Zonghao; Xie, Jiajia; Yin, Ming; Yang, Yun; Ding, Chengchao; Gao, Yong; Ma, Xiaoling
title: Interleukin-6 and Severity of COVID-19 Patients in Hefei, China
date: 2020-06-25
journal: Med Mal Infect
DOI: 10.1016/j.medmal.2020.06.005
sha: 78917d35c2db7221772a0c434c7818b03813383f
doc_id: 715118
cord_uid: 9iyys0w1

nan

J o u r n a l P r e -p r o o f According to existing reports, the COVID-19 pandemic resulted in more than 20% of severe cases that required critical care, and the case fatality is around 2.84% [1] . In the present study, we analyzed clinical and laboratory data from 75 patients with confirmed COVID-19 hospitalized in a designated hospital in Hefei, Anhui Province, China, and investigated potential indicators for infection severity.

The most common laboratory abnormalities observed in this study were decreased total lymphocytes, prolonged APTT, elevated LDH, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). Previous studies of COVID-19 patients in Wuhan suggested virus infection could induce a cytokine storm syndrome [2, 3] . Here most patients showed elevated inflammatory factors, e.g. CRP and ESR. Forty-nine patients were tested for IL-6, and 14 (28.57%) of them showed levels above the normal range, of which lymphocyte percentage, CD4 + , and CD8 + T cell counts were significantly decreased and neutrophil percentage, CRP, and LDH levels increased significantly, compared with patients with normal IL-6 range.

Further analysis of severe/critical and non-severe (i.e., mild and moderate) groups demonstrated that the severe group had significantly increased IL-6, CRP, PCT, and LDH levels. On the contrary, the same group had significantly decreased lymphocyte percentage, CD4 + , and CD8 + T cell counts although with higher number of total WBC and neutrophils ( Figure 2) . PCT values were within normal range in both groups. This data indicated a potential correlation between increased IL-6 levels and severity of the viral infection and the resulting inflammation.

IL-6 is produced at the inflammation site and is the chief stimulator of the acute phase response [4] . A complex of IL-6 and sIL-6Rα can activate endothelial cells to secrete IL-8 and monocyte chemoattractant protein (MCP)-1, and induce expression of adhesion molecules [5] . IL-6 also elicits specific cellular and humoral immune responses, including end-stage B cell differentiation, immunoglobulin secretion, and T cell activation. Elevated IL-6 might lead to redistribution of T cells in the lung and respiratory tract in response to the viral infection observed postmortem in COVID-19 patients [6] .

Similar to SARS-CoV, angiotensin converting enzyme II (ACE2) is also the cellular entry receptor of COVID-19 [7, 8] . ACE2 is highly expressed in human lung tissues, the gastrointestinal tract, vascular endothelial cells, and arterial smooth muscle cells [9] . Therefore, all of these organs might be targets for virus attack. Our study showed that LDH levels were increased in 44% of patients and significantly increased in the patient with higher IL-6 production and liver and/or kidney dysfunction (Table 1) . This data suggests strong evidence of multiple organ damage by the virus and predicts disease severity.

This study provides an assessment of the clinical and laboratory profiles of COVID-19 patients with various severity degrees in Hefei, China. Clinical manifestations of COVID-19 were nonspecific. Hematological profiles including lymphocytes, LDH, CRP, and procalcitonin, especially IL-6 might be used as indicators for disease severity and guidance for COVID-19 treatment. Figure 1 . Differences of laboratory findings between mild/moderate and severe/critical patients. (a) Absolute counts of WBC, neutrophils, and lymphocytes, (b) Percentage of neutrophils and lymphocytes, (c) CD4 + and CD8 + T cell counts, (d) ~ (f) Changes of infection indicators, CRP, PCT, and IL-6 in two groups, and (g) Detection of LDH levels. Data is presented as median (IQR) and analyzed by Mann-Whitney test. All statistical analyses were performed using GraphPad Prism 8.3. P values indicate differences between mild/moderate and severe/critical patients ( * p<.05, ** p<.005, *** p<.001, **** p<.0001). P <.05 was considered statistically significant.

Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis